| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.055 | 0.6 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |